Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Manganese transporter Slc30a10 controls physiological manganese excretion and toxicity
Courtney J. Mercadante, … , Deepa B. Rao, Thomas B. Bartnikas
Courtney J. Mercadante, … , Deepa B. Rao, Thomas B. Bartnikas
Published December 2, 2019; First published September 17, 2019
Citation Information: J Clin Invest. 2019;129(12):5442-5461. https://doi.org/10.1172/JCI129710.
View: Text | PDF
Categories: Research Article Genetics Metabolism

Manganese transporter Slc30a10 controls physiological manganese excretion and toxicity

  • Text
  • PDF
Abstract

Manganese (Mn), an essential metal and nutrient, is toxic in excess. Toxicity classically results from inhalational exposures in individuals who work in industrial settings. The first known disease of inherited Mn excess, identified in 2012, is caused by mutations in the metal exporter SLC30A10 and is characterized by Mn excess, dystonia, cirrhosis, and polycythemia. To investigate the role of SLC30A10 in Mn homeostasis, we first generated whole-body Slc30a10–deficient mice, which developed severe Mn excess and impaired systemic and biliary Mn excretion. Slc30a10 localized to canalicular membranes of hepatocytes, but mice with liver Slc30a10 deficiency developed minimal Mn excess despite impaired biliary Mn excretion. Slc30a10 also localized to the apical membrane of enterocytes, but mice with Slc30a10 deficiency in small intestines developed minimal Mn excess despite impaired Mn export into the lumen of the small intestines. Finally, mice with Slc30a10 deficiency in liver and small intestines developed Mn excess that was less severe than that observed in mice with whole-body Slc30a10 deficiency, suggesting that additional sites of Slc30a10 expression contribute to Mn homeostasis. Overall, these results indicated that Slc30a10 is essential for Mn excretion by hepatocytes and enterocytes and could be an effective target for pharmacological intervention to treat Mn toxicity.

Authors

Courtney J. Mercadante, Milankumar Prajapati, Heather L. Conboy, Miriam E. Dash, Carolina Herrera, Michael A. Pettiglio, Layra Cintron-Rivera, Madeleine A. Salesky, Deepa B. Rao, Thomas B. Bartnikas

×

Figure 7

Hepatocyte Slc30a10 deficiency, irrespective of hepatocyte Slc40a1 deficiency, leads to minimal Mn excess.

Options: View larger image (or click on image) Download as PowerPoint
Hepatocyte Slc30a10 deficiency, irrespective of hepatocyte Slc40a1 defic...
(A and B) Four-month-old Slc30a10lox/lox and Slc30a10lox/lox Alb mice were analyzed for (A) tissue Slc30a10/Hprt1 RNA ratios, normalized to female lox/lox levels. (B) Organ Mn levels. (C–F) Four-month-old Slc40a1fl/fl Slc30a10lox/lox and Slc40a1fl/fl Slc30a10lox/lox Alb mice were analyzed for (C and D) tissue RNA ratios of Slc30a10 (C) and Slc40a1 (D) to Hprt1, normalized to female fl/fl lox/lox levels, and (E and F) organ Mn (E) and iron (F) levels. In all panels, data are presented as individual values and represent the mean ± SEM. Outliers (not shown) were identified by ROUT. Two-tailed P values were calculated by unpaired t test. Removal of the outliers in A, B, and D did not alter the identification of comparisons with a P value below 0.05. No outliers were identified in C or F. Removal of the outlier in E (4.351 for male Slc30a10+/+ brain) changed the P value from P > 0.05 to P < 0.001. n = 5–7 replicates/group, except for female Slc30a10lox/lox, male Slc30a10lox/lox, and male Slc30a10lox/lox Alb (n = 4–5) mice. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts